Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 18.37% is in line with its 5-year average of 17.38%, around the middle of its 5-year range (7.31%–31.19%).
8.77% above its 12-month average of 16.89%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 22.48%.
GROSS MARGIN
18.37%
GROSS MARGIN AVG TTM
16.89%
GROSS MARGIN AVG 3Y
14.73%
GROSS MARGIN AVG 5Y
17.38%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+8.77%
CURRENT VS 3Y AVG
+24.73%
CURRENT VS 5Y AVG
+5.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.92%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
-57.20%
vs the sector median at left
Healthcare Triangle, Inc.
Market Cap
$8.48M
Gross Margin
18.37%
TTM Avg
16.89%
3Y Avg
14.73%
5Y Avg
17.38%
Market Cap
$8.47M
Gross Margin
-41.30%
TTM Avg
-15.77%
3Y Avg
-3.50%
5Y Avg
-3.50%
Market Cap
$8.28M
Gross Margin
0.00%
TTM Avg
-261.58%
3Y Avg
-106.09%
5Y Avg
-70.73%
Market Cap
$7.89M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.14M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.78M
Gross Margin
N/A
TTM Avg
-2933.43%
3Y Avg
-1696.98%
5Y Avg
-1166.77%
Market Cap
$9.27M
Gross Margin
92.64%
TTM Avg
97.85%
3Y Avg
48.93%
5Y Avg
32.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.48M | 18.37% | 16.89% | 14.73% | 17.38% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.47M | -41.30% | -15.77% | -3.50% | -3.50% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.28M | 0.00% | -261.58% | -106.09% | -70.73% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $7.78M | N/A | -2933.43% | -1696.98% | -1166.77% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.27M | 92.64% | 97.85% | 48.93% | 32.62% |
| Longeveron Inc. (LGVN)vs › | $7.46M | 69.76% | 72.87% | 54.39% | 49.20% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.56M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
18.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 22.48% |
| 2026-03-31 | 16.06% |
| 2025-12-31 | 14.30% |
| 2025-09-30 | 17.71% |
| 2025-06-30 | 13.88% |
| 2025-03-31 | 8.88% |
| 2024-12-31 | 11.69% |
| 2024-09-30 | 29.92% |
| 2024-06-30 | 12.20% |
| 2024-03-31 | 11.63% |
| 2023-12-31 | 21.67% |
| 2023-09-30 | 12.79% |
| 2023-06-30 | 13.43% |
| 2023-03-31 | 7.31% |
| 2022-12-31 | 11.83% |
| 2022-09-30 | 21.08% |
| 2022-06-30 | 19.98% |
| 2022-03-31 | 19.74% |
| 2021-12-31 | 16.12% |
| 2021-09-30 | 31.14% |
| 2021-06-30 | 31.19% |
| 2020-09-30 | 24.47% |
| 2020-06-30 | 23.88% |
